Next Article in Journal
Are We Underestimating Benthic Cyanotoxins? Extensive Sampling Results from Spain
Next Article in Special Issue
High Incidence and Levels of Ochratoxin A in Wines Sourced from the United States
Previous Article in Journal
Effects of Adding Clostridium sp. WJ06 on Intestinal Morphology and Microbial Diversity of Growing Pigs Fed with Natural Deoxynivalenol Contaminated Wheat
Previous Article in Special Issue
Differential Gene Expression Analysis of Bovine Macrophages after Exposure to the Penicillium Mycotoxins Citrinin and/or Ochratoxin A
 
 
Article

Immunohistochemical Analysis of Rat Renal Tumours Caused by Ochratoxin A

by 1 and 2,*
1
Pathology Department, County Hospital Timisoara, Timisoara 300736, Romania
2
Centre for Environmental Policy, Imperial College London, London SW7 2AZ, UK
*
Author to whom correspondence should be addressed.
Academic Editors: Richard A. Manderville and Annie Pfohl-Leszkowicz
Toxins 2017, 9(12), 384; https://doi.org/10.3390/toxins9120384
Received: 31 October 2017 / Revised: 21 November 2017 / Accepted: 24 November 2017 / Published: 28 November 2017
(This article belongs to the Collection Ochratoxins-Collection)
Experimental renal cancer caused by ochratoxin A (OTA) in rats was first defined in the US National Toxicology Program (1989) and raised questions about any aetiological role in human urinary tract tumours. A review of histopathology in several rat kidney tumours from dietary OTA in recently described London studies, augmented by clinical immunohistochemistry for the first time for this mycotoxin, establishes their renal tubular cell origin. It had been assumed that the toxin might cause the human urothelial tumours associated with Balkan endemic nephropathy, but the present study could not support this. Comparison with a similar review of a metastasising renal tumour from a female rat of the NTP study consistently shows the kidney as the primary carcinogenic site for OTA. Morphological heterogeneity of these kidney tumours as epithelioid and/or sarcomatoid is revealed. Leiomyosarcoma was also diagnosed, and rhabdomyosarcoma differentiation was observed in the exceptionally aggressive NTP female tumour. The present pilot study involving immunohistochemistry indicates need for wider review of archived tumours for experimental evidence before formulating any epidemiological basis from a rat model for OTA’s relevance to idiopathic human renal cell carcinoma. Although the NTP study concluded that females are less sensitive to OTA than males, some female tumours still had heterogeneous morphology. View Full-Text
Keywords: renal cell carcinoma; ochratoxin A; immunohistochemistry; urothelial cancer; leiomyosarcoma; rhabdomyosarcoma; Balkan endemic nephropathy renal cell carcinoma; ochratoxin A; immunohistochemistry; urothelial cancer; leiomyosarcoma; rhabdomyosarcoma; Balkan endemic nephropathy
Show Figures

Figure 1

MDPI and ACS Style

Herman, D.; Mantle, P. Immunohistochemical Analysis of Rat Renal Tumours Caused by Ochratoxin A. Toxins 2017, 9, 384. https://doi.org/10.3390/toxins9120384

AMA Style

Herman D, Mantle P. Immunohistochemical Analysis of Rat Renal Tumours Caused by Ochratoxin A. Toxins. 2017; 9(12):384. https://doi.org/10.3390/toxins9120384

Chicago/Turabian Style

Herman, Diana, and Peter Mantle. 2017. "Immunohistochemical Analysis of Rat Renal Tumours Caused by Ochratoxin A" Toxins 9, no. 12: 384. https://doi.org/10.3390/toxins9120384

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop